Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061542) titled 'Retrospective observational study evaluating the efficacy and safety of pemafibrate extended-release formulation in patients with dyslipidemia' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Meitetsu hospital
Condition:
Condition - Dyslipidemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To retrospectively evaluate the effects of pemafibrate extended-release formulation on lipid profiles, hepatic function, renal function, body composition, liver stiffness parameters, and safety in patients with dyslipidemia treated in routine clinical practic...